A detailed history of Tredje Ap Fonden transactions in Davita Inc. stock. As of the latest transaction made, Tredje Ap Fonden holds 8,848 shares of DVA stock, worth $1.37 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,848
Previous 8,848 -0.0%
Holding current value
$1.37 Million
Previous $1.23 Million 18.27%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$126.11 - $147.14 $17,024 - $19,863
-135 Reduced 1.5%
8,848 $1.23 Million
Q3 2023

Nov 09, 2023

SELL
$94.53 - $112.68 $88,763 - $105,806
-939 Reduced 9.46%
8,983 $849,000
Q2 2023

Aug 11, 2023

SELL
$81.58 - $100.93 $93,980 - $116,271
-1,152 Reduced 10.4%
9,922 $996,000
Q4 2022

Feb 10, 2023

SELL
$65.42 - $99.31 $8,308 - $12,612
-127 Reduced 1.13%
11,074 $827,000
Q3 2022

Nov 10, 2022

BUY
$80.24 - $95.27 $898,768 - $1.07 Million
11,201 New
11,201 $927,000
Q4 2019

Feb 10, 2020

SELL
$54.2 - $75.03 $89,917 - $124,474
-1,659 Closed
0 $0
Q3 2019

Nov 12, 2019

SELL
$52.55 - $63.28 $254,447 - $306,401
-4,842 Reduced 74.48%
1,659 $95,000
Q2 2019

Aug 09, 2019

SELL
$43.42 - $57.79 $121,228 - $161,349
-2,792 Reduced 30.04%
6,501 $366,000
Q1 2019

May 10, 2019

BUY
$49.95 - $59.21 $464,185 - $550,238
9,293 New
9,293 $505,000
Q2 2018

Aug 09, 2018

SELL
$62.77 - $73.47 $2.17 Million - $2.54 Million
-34,580 Closed
0 $0
Q1 2018

May 09, 2018

SELL
$65.0 - $80.03 $827,450 - $1.02 Million
-12,730 Reduced 26.91%
34,580 $2.28 Million
Q4 2017

Feb 12, 2018

SELL
$53.89 - $72.36 $1.79 Million - $2.41 Million
-33,245 Reduced 41.27%
47,310 $3.42 Million
Q3 2017

Nov 13, 2017

BUY
$56.13 - $64.78 $4.52 Million - $5.22 Million
80,555
80,555 $4.78 Million

Others Institutions Holding DVA

About DAVITA INC.


  • Ticker DVA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 91,300,000
  • Market Cap $14.2B
  • Description
  • DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine lab...
More about DVA
Track This Portfolio

Track Tredje Ap Fonden Portfolio

Follow Tredje Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tredje Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Tredje Ap Fonden with notifications on news.